A transcriptional switch governs fibroblast activation in heart disease
暂无分享,去创建一个
Saptarsi M. Haldar | Pawel F. Przytycki | K. Pollard | D. Srivastava | A. Padmanabhan | Sanjeev S. Ranade | M. Rosenfeld | Rajan Jain | T. McKinsey | R. Micheletti | M. Alexanian | Casey A. Gifford | Li Li | Yu Huang | Gaia Andreoletti | Bárbara González-Terán | Lin Ye | Franco Felix | Qiming Duan | A. Pelonero | Joshua G. Travers | Ricardo Linares-Saldana | Nandhini Sadagopan | C. Y. Lee | Ana C. Silva | P. Przytycki | G. Andreoletti | Angelo Pelonero | Michael Alexanian | C. Lee
[1] Andrew J. Hill,et al. A human cell atlas of fetal chromatin accessibility , 2020, Science.
[2] Catherine L. Worth,et al. Cells of the adult human heart , 2020, Nature.
[3] Weifeng He,et al. Molecular Mechanism of Mesenchyme Homeobox 1 in Transforming Growth Factor β1–Induced P311 Gene Transcription in Fibrosis , 2020, Frontiers in Molecular Biosciences.
[4] Saptarsi M. Haldar,et al. BET Bromodomain Proteins Regulate Transcriptional Reprogramming in Genetic Dilated Cardiomyopathy , 2020, bioRxiv.
[5] Katherine S. Pollard,et al. CellWalker integrates single-cell and bulk data to resolve regulatory elements across cell types in complex tissues , 2019, Genome biology.
[6] Saptarsi M. Haldar,et al. Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation. , 2019, Circulation research.
[7] J. Thompson,et al. RNA sequencing of transplant-stage idiopathic pulmonary fibrosis lung reveals unique pathway regulation , 2019, ERJ Open Research.
[8] Saptarsi M. Haldar,et al. Dynamic chromatin targeting of BRD4 stimulates cardiac fibroblast activation , 2019, bioRxiv.
[9] Lianfeng Zhang,et al. Meox1 accelerates myocardial hypertrophic decompensation through Gata4 , 2018, Cardiovascular research.
[10] L. Lau,et al. Resolution of organ fibrosis , 2018, Journal of Clinical Investigation.
[11] Saptarsi M. Haldar,et al. BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure , 2017, Science Translational Medicine.
[12] B. Aronow,et al. Genetic lineage tracing defines myofibroblast origin and function in the injured heart , 2016, Nature Communications.
[13] Leighton J. Core,et al. Base-pair-resolution genome-wide mapping of active RNA polymerases using precision nuclear run-on (PRO-seq) , 2016, Nature Protocols.
[14] Don C Rockey,et al. Fibrosis--a common pathway to organ injury and failure. , 2015, The New England journal of medicine.
[15] Howard Y. Chang,et al. ATAC‐seq: A Method for Assaying Chromatin Accessibility Genome‐Wide , 2015, Current protocols in molecular biology.
[16] J. Qi,et al. BET acetyl-lysine binding proteins control pathological cardiac hypertrophy. , 2013, Journal of molecular and cellular cardiology.
[17] Saptarsi M. Haldar,et al. BET Bromodomains Mediate Transcriptional Pause Release in Heart Failure , 2013, Cell.
[18] Luke A. Gilbert,et al. CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes , 2013, Cell.
[19] David A. Orlando,et al. Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes , 2013, Cell.
[20] William B. Smith,et al. Selective inhibition of BET bromodomains , 2010, Nature.
[21] J. Ragoussis,et al. A Large Fraction of Extragenic RNA Pol II Transcription Sites Overlap Enhancers , 2010, PLoS biology.
[22] M. Nguyen,et al. Lack of the mesodermal homeodomain protein MEOX1 disrupts sclerotome polarity and leads to a remodeling of the cranio-cervical joints of the axial skeleton. , 2009, Developmental biology.
[23] D. Rockey,et al. Fibrosis--A Common Pathway to Organ Injury and Failure. , 2015, The New England journal of medicine.
[24] M. Biddle,et al. A report from the American Heart Association Council on Cardiovascular and Stroke Nursing. , 2015, The Journal of cardiovascular nursing.